These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 36920694)
1. Pseudotyped Viruses for Marburgvirus and Ebolavirus. Zhang L; Liu S; Wang Y Adv Exp Med Biol; 2023; 1407():105-132. PubMed ID: 36920694 [TBL] [Abstract][Full Text] [Related]
2. The Inability of Marburg Virus to Cause Disease in Ferrets Is Not Solely Linked to the Virus Glycoprotein. Schiffman Z; Garnett L; Tran KN; Cao W; He S; Emeterio K; Tierney K; Azaransky K; Strong JE; Banadyga L J Infect Dis; 2023 Nov; 228(Suppl 7):S594-S603. PubMed ID: 37288605 [TBL] [Abstract][Full Text] [Related]
4. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates. Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042 [TBL] [Abstract][Full Text] [Related]
5. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus. Zhang Y; Zhang M; Wu H; Wang X; Zheng H; Feng J; Wang J; Luo L; Xiao H; Qiao C; Li X; Zheng Y; Huang W; Wang Y; Wang Y; Shi Y; Feng J; Chen G Elife; 2024 Mar; 12():. PubMed ID: 38526940 [TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of filamin A and B proteins in modulating filovirus entry. Shepley-McTaggart A; Liang J; Ding Y; Djurkovic MA; Kriachun V; Shtanko O; Sunyer O; Harty RN PLoS Pathog; 2023 Aug; 19(8):e1011595. PubMed ID: 37585478 [TBL] [Abstract][Full Text] [Related]
8. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection. Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918 [TBL] [Abstract][Full Text] [Related]
9. Development of a Měnglà virus minigenome and comparison of its polymerase complexes with those of other filoviruses. Xie SZ; Yao K; Li B; Peng C; Yang XL; Shi ZL Virol Sin; 2024 Jun; 39(3):459-468. PubMed ID: 38782261 [TBL] [Abstract][Full Text] [Related]
10. Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory. Yang W; Li W; Zhou W; Wang S; Wang W; Wang Z; Feng N; Wang T; Xie Y; Zhao Y; Yan F; Xia X Virol Sin; 2024 Jun; 39(3):434-446. PubMed ID: 38556051 [TBL] [Abstract][Full Text] [Related]
15. Structural and Energetic Basis for Differential Binding of Ebola and Marburg Virus Glycoproteins to a Bat-Derived Niemann-Pick C1 Protein. Igarashi M; Hirokawa T; Takada A J Infect Dis; 2023 Nov; 228(Suppl 7):S479-S487. PubMed ID: 37119290 [TBL] [Abstract][Full Text] [Related]
17. Reverse genetics systems as tools for the development of novel therapies against filoviruses. Hoenen T; Feldmann H Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1253-63. PubMed ID: 25169588 [TBL] [Abstract][Full Text] [Related]